Sk Inc. (034730)
KRX SM KRX SM Primary Summary
034730 Chart
Sk Inc. (034730) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sk Inc. ever had a stock split?
Sk Inc. Profile
| Industrial Conglomerates Industry | Industrials Sector | Mr. Tae-won Chey CEO | KRX SM Exchange | KR7034730002 ISIN |
| South Korea Country | 4,033 Employees | 31 Mar 2026 Last Dividend | - Last Split | - IPO Date |
Overview
SK Inc., originally established as SK Holdings Co., Ltd, is a South Koren conglomerate that pivoted its corporate identity in March 2021 to reflect its diversified interests across various innovative and essential sectors. Founded in 1991 and headquartered in Seoul, South Korea, SK Inc. has expanded its operations to become a key player in the development and distribution of advanced materials, sustainable energy solutions, and cutting-edge life sciences and biopharmaceutical technologies. Furthermore, the company has ventured into digital businesses, showcasing its adaptability and commitment to innovation. This multifaceted approach allows SK Inc. to not only lead in technological advancements but also contribute to global solutions in health, energy, and the digital economy.
Products and Services
- Advanced Materials
- Energy
- Life Sciences and Biopharmaceuticals
- Digital Businesses
SK Inc. develops and supplies a range of advanced materials critical for various industrial applications. These materials are key components in electronics, semiconductors, and automotive industries, providing innovative solutions that enhance performance and sustainability.
The company's energy segment is dedicated to creating sustainable energy solutions. This includes investments and development in renewable energy sources, such as solar and wind, as well as more traditional energy markets to support the global transition towards a more sustainable energy future.
SK Inc.’s commitment to improving human health is evident in its life sciences and biopharmaceutical divisions. From the development of new drugs and treatments to the advancement of medical technology, the company seeks to address pressing health challenges and improve the quality of life for people around the world.
In the era of digital transformation, SK Inc. has actively pursued opportunities within digital industries. This includes digital health solutions, AI technologies, and digital platforms designed to enhance business efficiency and consumer experiences. Through these initiatives, SK Inc. is positioned at the forefront of digital innovation.
